首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Extremely high prevalence of multidrug resistant tuberculosis in Murmansk, Russia: a population-based study.
【24h】

Extremely high prevalence of multidrug resistant tuberculosis in Murmansk, Russia: a population-based study.

机译:俄罗斯摩尔曼斯克的耐多药结核病极高流行:一项基于人群的研究。

获取原文
获取原文并翻译 | 示例
       

摘要

Drug resistance and molecular epidemiology of tuberculosis (TB) in the Murmansk region was investigated in a 2-year, population-based surveillance of the civilian population. During 2003 and 2004, isolates from all culture-positive cases were collected (n = 1,226). Prevalence of multi-drug resistance (MDR) was extremely high, as 114 out of 439 new cases (26.0%), and 574 out of 787 previously treated cases (72.9%) were resistant to at least isoniazid (INH) and rifampin (RIF). Spoligotyping of the primary MDR-TB isolates revealed that most isolates grouped to the Beijing SIT1 genotype (n = 91, 79.8%). Isolates of this genotype were further analyzed by IS6110 RFLP. Sequencing of gene targets associated with INH and RIF resistance further showed that the MDR-TB strains are highly homogeneous as 78% of the MDR, SIT1 strains had the same resistance-conferring mutations. The genetic homogeneity of the MDR-TB strains indicates that they are actively transmitted in Murmansk.
机译:在对摩尔曼斯克地区的居民进行为期2年的基于人口的监测中,调查了摩尔曼斯克州的耐药性和结核病分子流行病学。在2003年和2004年期间,收集了所有培养阳性病例的分离株(n = 1,226)。多药耐药性(MDR)的患病率极高,因为439例新病例中有114例(26.0%),而787例先前治疗的病例中有574例(72.9%)至少对异烟肼(INH)和利福平(RIF)耐药)。对主要耐多药结核病菌株的血吸虫分型显示,大多数菌株与北京SIT1基因型分组(n = 91,79.8%)。 IS6110 RFLP进一步分析了该基因型的分离株。与INH和RIF耐药性相关的基因靶标的测序进一步表明,MDR-TB菌株高度均一,因为78%的MDR,SIT1菌株具有相同的赋予耐药性的突变。 MDR-TB菌株的遗传同质性表明它们在摩尔曼斯克活跃地传播。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号